Qiagen is the global leader in molecular biology and sample preparation, trusted by laboratories worldwide for solutions that turn complex science into clear, actionable answers. Their reagents form the foundation of modern diagnostics, empowering labs to analyze DNA, RNA, and proteins with accuracy and consistency. From infectious disease testing and oncology to genetic profiling and personalized medicine, Qiagen reagents are the key to unlocking the future of healthcare.
Every Qiagen reagent is engineered to deliver reproducible, high-quality results—even with challenging samples. Their portfolio spans PCR, real-time PCR, sequencing, next-generation sequencing (NGS), and nucleic acid extraction reagents, all designed to streamline workflows and minimize errors. For laboratories under pressure to deliver fast and reliable results, Qiagen offers the precision and dependability needed to make confident clinical decisions.
Through Southern Medical Supplies Limited (SMSL), bioMérieux’s world-class reagents are available across the Caribbean, empowering local laboratories to operate at the same standard as the most advanced facilities worldwide. Whether it’s routine microbiology testing or responding to urgent infectious disease challenges, SMSL ensures laboratories have the tools, expertise, and supply chain support to stay ahead of diagnostic demands.
Through Southern Medical Supplies Limited (SMSL), Qiagen’s world-class reagents are now available across the Caribbean, giving local laboratories access to the same advanced tools trusted by institutions in North America and Europe. With Qiagen and SMSL, Caribbean labs can expand their testing capabilities, respond more effectively to outbreaks, and support advanced healthcare initiatives such as cancer screening and genetic testing.
In today’s evolving healthcare landscape, precision medicine is no longer optional—it’s essential. Qiagen reagents enable laboratories to move beyond routine testing into advanced diagnostics that uncover the unique biology of every patient. By supporting earlier detection, more targeted therapies, and better monitoring, Qiagen helps clinicians improve patient outcomes while reducing costs and inefficiencies.
When laboratories choose Qiagen reagents through SMSL, they gain more than products—they gain a partner committed to excellence. SMSL provides local service, training, and technical expertise to ensure every reagent performs at its best. Together, Qiagen and SMSL deliver a powerful combination of global molecular innovation and regional support, driving the next generation of diagnostics across the Caribbean.
